Brightstar Capital Partners has announced the acquisition of Analyte Health.
Analyte, founded in 2010 and based in Houston, is a digital health company that provides direct-to-consumer diagnostics and treatment, with services spanning clinical testing, virtual care and prescription fulfillment.
Brightstar, founded in 2015 and with headquarters in New York and West Palm Beach, Florida, is a middle market private equity firm. It is focused on investing in business services, industrials, consumer, and government services and technology companies.
Terms of the acquisition were not disclosed.
